US
QHSLab, Inc.
USAQ · OTC
$0.30 -6.25% (-$0.02)
1M -14.29%
Market Cap $4.81M
P/E Ratio 9.18x
Div. Yield -
ROE 51.21%
Bulios Fair Price
$0.41
36.7% upside
Trenutna cena
$0.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica USAQ trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
93 /100
Cheap P/E 9.18x
P/B 3.09x
EV/EBITDA 6.39x
Growth
100 /100
Growing Rev. growth 29.37%
Book val. growth 177.25%
EPS growth N/A
Profitability
43 /100
Moderate Gross margin 66.50%
FCF margin 3.56%
Net margin 17.37%
Quality
70 /100
Excellent ROIC 4.99%
Asset turnover 1.56x
ROE 51.21%
Debt
90 /100
Low Debt/Equity 0.06x
Net debt/EBITDA -0.31x
Current ratio 1.82x
Stability
48 /100
Moderate Beta 0.60x
Profitable years 1
Rev. volatility 19.31%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o USAQ
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Troy James Grogan
Employees
12
Headquarters
West Palm Beach
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report